Weirong Zhu

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Lijing Jiao, Jianfang Xu, Jianli Sun et al. · Frontiers in Pharmacology · 2019 · 50 citations · Full text

Medicine, Oncology, Pharmacology +14

Nobiletin inhibits breast cancer cell migration and invasion by suppressing the IL-6-induced ERK-STAT and JNK-c-JUN pathways

Yuan Wu, Qiong Li, Lingling Lv et al. · Phytomedicine · 2022 · 43 citations

Medicine, Oncology, Pharmacology +8

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial

Qin Wang, Lijing Jiao, Shengfei Wang et al. · Frontiers in Pharmacology · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15

Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Qin Wang, Lijing Jiao, Shengfei Wang et al. · Biological Procedures Online · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

The mechanism of FZXJJZ decoction suppresses colorectal liver metastasis via the VDR/TGF-β/Snail1 signaling pathways based on network pharmacology-TCGA data-transcriptomics analysis

Qiong Li, Jingxian Chen, Yuan Wu et al. · Journal of Ethnopharmacology · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17